FibroGen, Inc. ( FGEN) - Stock Earnings
Stock symbol FGEN is outdated, potentially delisted? Maybe it is available on other exchange?
Ticker FGEN was renamed to
KYNB
effective 2026-01-08.
FGEN Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q1 | 4.6 million USD | 2.7 million USD |
| 2025Q2 | -7.6 million USD | 1.3 million USD |
| 2025Q3 | 200.6 million USD | 1.1 million USD |
FGEN Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -293.7 million USD | 140.7 million USD |
| 2023 | -284.2 million USD | 46.8 million USD |
| 2024 | -47.6 million USD | 29.6 million USD |
FGEN
Price: $9.71
52 week price:
Payout Ratio Range:
Earnings Per Share: -12.85 USD
P/E Ratio: -0.71
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.0 million
Ebitda: -33.4 millionMarket Capitalization: 37.1 million